Indicators
Indicators
Value
Direction
MACD(12,26,9)
0.286
Buy
RSI(14)
70.014
Buy
STOCH(KDJ)(9,3,3)
87.625
Overbought
ATR(14)
1.741
High Vlolatility
CCI(14)
180.704
Buy
Williams %R
4.754
Overbought
TRIX(12,20)
0.357
Sell
StochRSI(14)
100.000
Buy
Encompass Health Corp
EHC125.580USD
+1.115+0.90%
Close 09/05, 16:00（ET）Quotes delayed by 15 min
12.65BMarket Cap
24.31P/E TTM
TradingKey Stock Score
Overall Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Peer Comparison
TradingKey Stock Score
Currency: USD Updated：2025-09-05Key Insights
The company's fundamentals are relatively healthy. Its valuation is considered undervalued,and institutional recognition is very high. Over the past 30 days, multiple analysts have rated the company as a Buy. Despite a weak stock market performance, the company shows strong fundamentals and technicals. The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.
Score
Support & Resistance
No Data
Score Analysis
Current score
Previous score
Analyst Rating
Based on
13
analysts
Buy
Current Rating
135.750
Target Price
+8.10%
Upside Space
Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.
Company Highlights
StrengthsRisks
Encompass Health Corporation is an owner and operator of inpatient rehabilitation hospitals in the United States. The Company provides compassionate rehabilitative care for patients recovering from a major injury or illness, using advanced technology and treatments to maximize recovery. It operates hospitals in 38 states and Puerto Rico, with concentrations in Florida and Texas. It operates approximately 166 inpatient rehabilitation hospitals. Its inpatient rehabilitation hospitals offer specialized rehabilitative care across an array of diagnoses and deliver comprehensive patient care services. It provides care to patients who suffer from cognitive disabilities or injuries due to medical conditions, such as strokes, hip fractures and a variety of debilitating neurological conditions. Its hospitals have settings for treating the debilitating effects of the COVID-19 virus, such as significant muscle weakness, cognitive impairments, shortness of breath with activity and malnutrition.
High Growth
The company's revenue has grown steadily over the past 3 years, averaging 23.56% year-on-year.
High Profit Growth
The company's net income leads the industry, with the latest annual income totaling USD 67.87.
High Dividend
The company is a high dividend payer, with the latest dividend payout ratio of 14.29%.
Stable Dividend
The company has regularly paid dividends over the past 5 years, with the latest dividend payout ratio of 14.29%.
Overvalued
The company’s latest PE is 24.15, at a high 3-year percentile range.
Institutional Selling
The latest institutional holdings are 98.99M shares, decreasing 3.28% quarter-over-quarter.
Held by The Vanguard
Star Investor The Vanguard holds 10.36M shares of this stock.
Financial Health
Currency: USD Updated：2025-09-05The company's current financial score is 7.58, which is higher than the Healthcare Services & Equipment industry's average of 7.15. Its financial status is stable, and its operating efficiency is average. Its latest quarterly revenue reached 1.46B, representing a year-over-year increase of 10.59%, while its net profit experienced a year-over-year increase of 35.27%.
Score
Financials
6.51
Key Metrics
Cash and cash equivalents
Total assets
Total liabilities
Free cash flow
No Data
Quality of Earnings
7.55
Operational Efficiency
7.55
Growth Potential
7.30
Shareholder Returns
9.02
Company Valuation
Currency: USD Updated：2025-09-05The company’s current valuation score is 1.80, which is lower than the Healthcare Services & Equipment industry's average of 2.15. Its current P/E ratio is 23.77, which is 1.05% below the recent high of 24.02 and 10.94% above the recent low of 21.17.
Score
Valuation Dimensions
P/E
P/B
P/S
P/CF
Industry Ranking 11/280
No Data
Earnings Forecast
Currency: USD Updated：2025-09-05The company’s current earnings forecast score is 8.92, which is higher than the Healthcare Services & Equipment industry's average of 7.66. The average price target for Encompass Health Corp is 135.00, with a high of 145.00 and a low of 125.00.
Score
Support & Resistance
No Data
Analyst Rating
Based on
13
analysts
Buy
Current Rating
135.750
Target Price
+8.10%
Upside Space
Strong Buy
Buy
Hold
Sell
Strong Sell
Peer Comparison
69
Total
7
Median
8
Average
Company name
Ratings
Analysts
Encompass Health Corp
EHC
13
CVS Health Corp
CVS
29
HCA Healthcare Inc
HCA
27
Teladoc Health Inc
TDOC
27
Tenet Healthcare Corp
THC
24
Natera Inc
NTRA
22
1
2
3
...
14
Financial Forecasting
EPS
Revenue
Net Profit
EBIT
No Data
Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.
Price Momentum
Currency: USD Updated：2025-09-05The company’s current price momentum score is 9.70, which is higher than the Healthcare Services & Equipment industry's average of 7.47. Sideways: Currently, the stock price is trading between the resistance level at 129.66 and the support level at 112.52, making it suitable for range-bound swing trading.
Score
Support & Resistance
No Data
Indicators
The Indicators feature provides value and direction analysis for various instruments under a selection of technical indicators, together with a technical summary.
This feature includes nine of the commonly used technical indicators: MACD, RSI, KDJ, StochRSI, ATR, CCI, WR, TRIX and MA. You may also adjust the timeframe depending on your needs.
Please note that technical analysis is only part of investment reference, and there is no absolute standard for using numerical values to assess direction. The results are for reference only, and we are not responsible for the accuracy of the indicator calculations and summaries.
Moving Average
Indicators
Value
Direction
MA5
123.830
Buy
MA10
123.314
Buy
MA20
121.764
Buy
MA50
117.015
Buy
MA100
116.603
Buy
MA200
107.421
Buy
Institutional Confidence
Currency: USD Updated：2025-09-05The company’s current institutional recognition score is 10.00, which is higher than the Healthcare Services & Equipment industry's average of 7.19. The latest institutional shareholding proportion is 98.28%, representing a quarter-over-quarter decrease of 2.30%. The largest institutional shareholder is The Vanguard, holding a total of 10.36M shares, representing 10.28% of shares outstanding, with 0.21% decrease in holdings.
Score
Institutional Shareholding
No Data
Shareholder Activity
Name
Shares Held
Chg %
BlackRock Institutional Trust Company, N.A.
Invesco Advisers, Inc.
Wellington Management Company, LLP
State Street Global Advisors (US)
T. Rowe Price Investment Management, Inc.
AllianceBernstein L.P.
Fuller & Thaler Asset Management Inc.
Geode Capital Management, L.L.C.
Fidelity Management & Research Company LLC
1
2
Risk Assessment
Currency: USD Updated：2025-09-05The company's beta value is 0.93. This indicates that the stock tends to underperform the index during upward trending markets but experiences smaller declines during downward trending markets.
Score
Beta vs S&P 500 index
0.95
VaR
+2.32%
240-Day Maximum Drawdown
+12.64%
240-Day Volatility
+29.16%
Return
Best Daily Return
60 days
+4.00%
120 days
+11.79%
5 years
+11.79%
Worst Daily Return
60 days
-10.35%
120 days
-10.35%
5 years
-10.35%
Sharpe Ratio
60 days
+0.80
120 days
+2.12
5 years
+0.74
Risk Assessment
Maximum Drawdown
240 days
+12.64%
3 years
+18.45%
5 years
+39.10%
Return-to-Drawdown Ratio
240 days
+2.88
3 years
+2.79
5 years
+0.49
Skewness
240 days
+0.44
3 years
+0.74
5 years
+0.36
Volatility
Realised Volatility
240 days
+29.16%
5 years
+27.53%
Standardised True Range
240 days
+1.84%
5 years
+1.27%
Downside Risk-Adjusted Return
120 days
+230.20%
240 days
+230.20%
Maximum Daily Upside Volatility
60 days
+17.92%
Maximum Daily Downside Volatility
60 days
+23.93%
Liquidity
Average Turnover Rate
60 days
+0.86%
120 days
+0.85%
5 years
--
Turnover Deviation
20 days
+19.76%
60 days
+23.99%
120 days
+23.02%
Peer Comparison
Currency: USD Updated：2025-09-05Encompass Health Corp
EHC
7.52 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Insulet Corp
PODD
7.89 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Merit Medical Systems Inc
MMSI
7.81 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Tenet Healthcare Corp
THC
7.67 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Brightspring Health Services Inc
BTSG
7.65 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Thermo Fisher Scientific Inc
TMO
7.64 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
View more
The Stock Score data is powered by TradingKey and updated daily. Rating data is sourced from LESG. Please use the data with caution for reference purposes only.
